NewsChinese CBD Market In The Sights Of Yooma After...

Chinese CBD Market In The Sights Of Yooma After £6m EMMAC Deal


UK cannabis business EMMAC Life Sciences Group has sold its Yooma Wellness business for over $8m with the emerging Chinese wellness market in the sights of its new owners.

Canadian Securities Exchange-listed Yooma has acquired the Blossom, MYO, Hello Joya and What the Hemp brands which have a strong presence Asia.

EMMAC and Yooma had previously signed a licensing agreement on the Yooma brands in January this year.

Ron Wardle, Co-CEO of Yooma, said the deal would allow it to target the fast-growing European market, ‘particularly in the UK where MYO Plant Nutrition‘s supplements are gaining tremendous traction with some national retailers’. 

Strategic Focus

He added: ”We also intend to continue our focus on China and rebrand Blossom, with plans to launch in certain Asian markets later this year.”

Antonio Costanzo, CEO of EMMAC, said: “EMMAC’s strategic focus is to accelerate the growth of its medical cannabis and B2B wellness business operations.” 

The total purchase price is approximately US$8.1m, and will be payable as 7,459,981 shares of Yooma valued at CA$1.384.

Yooma is an emerging marketer and distributor of cannabinoid and hemp-derived wellness products. EMMAC is Europe’s largest independent cannabis company, bringing together science and research with ccultivation, extraction and production. 

It is an investee company of FastForward Innovations Ltd, an AIM quoted company focusing on making investments in cannabis and other fast-growing industries

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tetra Pharm Technologies Secures €9 Million In Series A Round To Expand R&D Operations

PRESS RELEASE THE Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a...

European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues

Oxford Cannabinoid Technologies  THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the...

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.  On Tuesday,...

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK And EU Market Position

PRESS RELEASE 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...

Czechia Could Be A ‘Step Towards Convincing The Rest Of Europe To Create A Legal Cannabis Framework’

EARLIER this week, Czechia’s national anti-drug coordinator Jindřich Vobořil, described as the ‘locomotive’ driving rapid cannabis reform in the...

Hellenic Dynamics ‘On Track’ To Supply Flowers To Germany By Mid 2023

PRESS RELEASE Hellenic Dynamics' core strategy is to develop and operate its 40,000 square metre active THC cultivation licence from...

Must read

You might also likeRELATED
Recommended to you